All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Heartseed

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

JAPAN Japan

Post An Enquiry

ASCO 2020

Participation Not Confirmed

Update your events

Heartseed and ITOCHU CHEMICAL FRONTIER Sign Capital Alliance Agreement

Contact the Supplier

Lead Product(s): Allogeneic iPSC-derived cardiomyocytes

Therapeutic Area: Cardiology/Vascular Diseases

Highest Development Status: Phase I Product Type: Large molecule

Partner/Sponsor/Collaborator: Itochu Chemical Frontier

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement March 10, 2020

Details:

Through this partnership, Heartseed will leverage ICF’s global network of academia and research institutions to explore iPS-Cell and Cardiomyocyte-related business opportunities.